======= GPR55 ======= == Gene Information == * **Official Symbol**: GPR55 * **Official Name**: G protein-coupled receptor 55 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9290|9290]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y2T6|Q9Y2T6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GPR55&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPR55|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604107|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: May be involved in hyperalgesia associated with inflammatory and neuropathic pain (By similarity). Receptor for L- alpha-lysophosphatidylinositol (LPI). LPI induces Ca(2+) release from intracellular stores via the heterotrimeric G protein GNA13 and RHOA. Putative cannabinoid receptor. May play a role in bone physiology by regulating osteoclast number and function. {ECO:0000250, ECO:0000269|PubMed:19805329}. |7tm 1| |cannabinoid receptor activity| |cannabinoid signaling pathway| |bone resorption| |negative regulation of osteoclast differentiation| |positive regulation of Rho protein signal transduction| |activation of phospholipase C activity| |positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway| |positive regulation of phospholipase C activity| |negative regulation of myeloid leukocyte differentiation| |regulation of phospholipase C activity| |bone remodeling| |positive regulation of phospholipase activity| |positive regulation of Ras protein signal transduction| |regulation of osteoclast differentiation| |positive regulation of small GTPase mediated signal transduction| |positive regulation of lipase activity| |regulation of phospholipase activity| |negative regulation of myeloid cell differentiation| |phospholipase C-activating G protein-coupled receptor signaling pathway| |regulation of lipase activity| |negative regulation of leukocyte differentiation| |tissue remodeling| |regulation of myeloid leukocyte differentiation| |negative regulation of hemopoiesis| |regulation of Rho protein signal transduction| |tissue homeostasis| |positive regulation of ERK1 and ERK2 cascade| |regulation of myeloid cell differentiation| |regulation of Ras protein signal transduction| |regulation of leukocyte differentiation| |positive regulation of cytosolic calcium ion concentration| |regulation of ERK1 and ERK2 cascade| |multicellular organismal homeostasis| |regulation of cytosolic calcium ion concentration| |anatomical structure homeostasis| |regulation of small GTPase mediated signal transduction| |cellular calcium ion homeostasis| |negative regulation of immune system process| |calcium ion homeostasis| |regulation of hemopoiesis| |cellular divalent inorganic cation homeostasis| |divalent inorganic cation homeostasis| |positive regulation of MAPK cascade| |cellular metal ion homeostasis| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |cation homeostasis| |negative regulation of cell differentiation| |inorganic ion homeostasis| |G protein-coupled receptor activity| |cellular chemical homeostasis| |regulation of MAPK cascade| |positive regulation of hydrolase activity| |ion homeostasis| |cellular homeostasis| |negative regulation of developmental process| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |chemical homeostasis| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |regulation of hydrolase activity| |G protein-coupled receptor signaling pathway| |integral component of plasma membrane| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |homeostatic process| |positive regulation of signal transduction| |regulation of immune system process| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.74| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|1.9| |[[:results:exp331|A-769662 20μM R07 exp331]]|1.97| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.13| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5287 * **Expression level (log2 read counts)**: 1.11 {{:chemogenomics:nalm6 dist.png?nolink |}}